Editorial: Deprescribing and Minimizing Use of Anticholinergic Medications

dc.contributor.authorSoiza, Roy L.
dc.contributor.authorBoustani, Malaz A.
dc.contributor.authorCampbell, Noll L.
dc.contributor.authorMangoni, Arduino A.
dc.contributor.departmentMedicine, School of Medicine
dc.date.accessioned2024-10-24T13:53:22Z
dc.date.available2024-10-24T13:53:22Z
dc.date.issued2021-12-15
dc.eprint.versionFinal published version
dc.identifier.citationSoiza RL, Boustani MA, Campbell NL, Mangoni AA. Editorial: Deprescribing and Minimizing Use of Anticholinergic Medications. Front Pharmacol. 2021;12:820051. Published 2021 Dec 15. doi:10.3389/fphar.2021.820051
dc.identifier.urihttps://hdl.handle.net/1805/44206
dc.language.isoen_US
dc.publisherFrontiers Media
dc.relation.isversionof10.3389/fphar.2021.820051
dc.relation.journalFrontiers in Pharmacology
dc.rightsAttribution 4.0 Internationalen
dc.rights.urihttps://creativecommons.org/licenses/by/4.0
dc.sourcePMC
dc.subjectAnticholinergic
dc.subjectAntimuscarinic
dc.subjectDrug safety
dc.subjectMedication withdrawal
dc.subjectMedicines optimisation
dc.subjectPrescribing
dc.titleEditorial: Deprescribing and Minimizing Use of Anticholinergic Medications
dc.typeArticle
Files
Original bundle
Now showing 1 - 1 of 1
Loading...
Thumbnail Image
Name:
Soiza2021Editorial-CCBY.pdf
Size:
516.06 KB
Format:
Adobe Portable Document Format
License bundle
Now showing 1 - 1 of 1
No Thumbnail Available
Name:
license.txt
Size:
2.04 KB
Format:
Item-specific license agreed upon to submission
Description: